Log in to your Inderes Free account to see all free content on this page.
Coegin Pharma
3.39 SEK
-7.12 %
Less than 1K followers
COEGIN
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-7.12 %
-12.85 %
-20.42 %
-23.65 %
-46.36 %
-18.51 %
-71.37 %
-86.30 %
-89.34 %
Coegin Pharma is a Swedish biotechnology company in commercial phase, developing science-based innovations for hair and skin. The company's patented ingredient for hair growth is now available in products sold through selected partners. A peptide for natural skin pigmentation is also in development with a planned launch in the near future. Coegin Pharma is headquartered in Lund.
Read moreMarket cap
96.92M SEK
Turnover
407.36K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue K
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
21.5.
2026
Interim report Q1'26
21.5.
2026
General meeting '26
19.8.
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Notice of annual general meeting in Coegin Pharma AB (publ)
Coegin Pharma expands commercial strategy with own-brand distribution model - launches VEXIENNE®
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio